As part of long-term management, the HgbA1C target for type 1 diabetes is ideally maintained at which range?

Enhance your readiness for the Physician Assistant Clinical Knowledge Rating and Assessment Tool (PACKRAT) 4 Exam. Utilize our flashcards and multiple-choice questions, complete with hints and explanations, to ace your upcoming test!

Multiple Choice

As part of long-term management, the HgbA1C target for type 1 diabetes is ideally maintained at which range?

Explanation:
Managing type 1 diabetes over the long term aims to keep HbA1c as close to normal as safely possible while avoiding hypoglycemia. HbA1c reflects average blood glucose over about three months, so lowering it reduces the risk of microvascular complications such as retinopathy, nephropathy, and neuropathy. For most adults with type 1 diabetes, targeting HbA1c in the lower-to-mid range of value is considered ideal, because it meaningfully reduces complication risk without pushing the patient into frequent dangerous lows. This balance—tight enough to curb long-term damage but not so tight that hypoglycemia becomes common or severe—explains why the commonly taught target sits around six to seven percent. In practice, some patients may aim slightly tighter if they can avoid hypoglycemia safely and if it’s clinically appropriate, while others with recurrent hypoglycemia or other risks may have a higher target.

Managing type 1 diabetes over the long term aims to keep HbA1c as close to normal as safely possible while avoiding hypoglycemia. HbA1c reflects average blood glucose over about three months, so lowering it reduces the risk of microvascular complications such as retinopathy, nephropathy, and neuropathy. For most adults with type 1 diabetes, targeting HbA1c in the lower-to-mid range of value is considered ideal, because it meaningfully reduces complication risk without pushing the patient into frequent dangerous lows. This balance—tight enough to curb long-term damage but not so tight that hypoglycemia becomes common or severe—explains why the commonly taught target sits around six to seven percent. In practice, some patients may aim slightly tighter if they can avoid hypoglycemia safely and if it’s clinically appropriate, while others with recurrent hypoglycemia or other risks may have a higher target.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy